Adcon I
Alternative Names: Adcon-ILatest Information Update: 22 Dec 2003
At a glance
- Originator Gliatech (CEASED)
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Post-surgical adhesions
Most Recent Events
- 22 Dec 2003 Discontinued - Clinical-Phase-Unknown for Post-surgical adhesions in USA (Topical)
- 26 Sep 2002 Gliatech is auctioning its Adcon® assets
- 17 May 2002 Gliatech has filed a petition for bankruptcy protection